3Année·

After the spin-off and the spin-off of the Consumer Health division, my investment case in GSK no longer fits.

25.07

GlaxoSmithkline

Vendu à 21,00 €

1 Commentaire

Cashcocktail@CashCocktail

3Année

I have been watching the spin-off company for a while, should (and I hope so) the company be sold off afterwards, the spin-off will go into my portfolio... either the managers no longer want the spin-off in the portfolio or for other reasons such as portfolio compositions

•